Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants.

Beardsall K, Thomson L, Elleri D, Dunger DB, Hovorka R.

Arch Dis Child Fetal Neonatal Ed. 2019 Aug 9. pii: fetalneonatal-2019-316871. doi: 10.1136/archdischild-2019-316871. [Epub ahead of print]

PMID:
31399480
2.

Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery.

Dovc K, Boughton C, Tauschmann M, Thabit H, Bally L, Allen JM, Acerini CL, Arnolds S, de Beaufort C, Bergenstal RM, Campbell F, Criego A, Dunger DB, Elleri D, Evans ML, Fröhlich-Reiterer E, Hofer S, Kapellen T, Leelarathna L, Pieber TR, Rami-Merhar B, Shah VN, Sibayan J, Wilinska ME, Hovorka R; APCam11, AP@Home, and KidsAP Consortia.

Diabetes Care. 2019 Jul;42(7):1344-1347. doi: 10.2337/dc18-2625. Epub 2019 May 21.

PMID:
31221700
3.

Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.

Lawton J, Blackburn M, Rankin D, Allen JM, Campbell FM, Leelarathna L, Tauschmann M, Thabit H, Wilinska ME, Elleri D, Hovorka R.

Diabetes Technol Ther. 2019 Mar;21(3):119-127. doi: 10.1089/dia.2018.0306. Epub 2019 Feb 5.

4.

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.

Tauschmann M, Thabit H, Bally L, Allen JM, Hartnell S, Wilinska ME, Ruan Y, Sibayan J, Kollman C, Cheng P, Beck RW, Acerini CL, Evans ML, Dunger DB, Elleri D, Campbell F, Bergenstal RM, Criego A, Shah VN, Leelarathna L, Hovorka R; APCam11 Consortium.

Lancet. 2018 Oct 13;392(10155):1321-1329. doi: 10.1016/S0140-6736(18)31947-0. Epub 2018 Oct 3. Erratum in: Lancet. 2018 Oct 13;392(10155):1310.

5.

Targeting glucose control in preterm infants: pilot studies of continuous glucose monitoring.

Thomson L, Elleri D, Bond S, Howlett J, Dunger DB, Beardsall K.

Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F353-F359. doi: 10.1136/archdischild-2018-314814. Epub 2018 Sep 19.

6.

Patients' and caregivers' experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study.

Lawton J, Blackburn M, Allen J, Campbell F, Elleri D, Leelarathna L, Rankin D, Tauschmann M, Thabit H, Hovorka R.

BMC Endocr Disord. 2018 Feb 20;18(1):12. doi: 10.1186/s12902-018-0239-1.

7.

Fifteen-minute consultation: Insulin pumps for type 1 diabetes in children and young people.

Prentice P, Elleri D.

Arch Dis Child Educ Pract Ed. 2018 Jun;103(3):131-136. doi: 10.1136/archdischild-2016-310884. Epub 2018 Jan 3.

PMID:
29298818
8.

Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.

Bally L, Thabit H, Tauschmann M, Allen JM, Hartnell S, Wilinska ME, Exall J, Huegel V, Sibayan J, Borgman S, Cheng P, Blackburn M, Lawton J, Elleri D, Leelarathna L, Acerini CL, Campbell F, Shah VN, Criego A, Evans ML, Dunger DB, Kollman C, Bergenstal RM, Hovorka R.

BMJ Open. 2017 Jul 13;7(7):e016738. doi: 10.1136/bmjopen-2017-016738.

9.

Tolvaptan use during hyperhydration in paediatric intracranial lymphoma with SIADH.

Willemsen RH, Delgado-Carballar V, Elleri D, Thankamony A, Burke GA, Nicholson JC, Dunger DB.

Endocrinol Diabetes Metab Case Rep. 2016;2016. pii: 16-0066. Epub 2016 Nov 1.

10.

Modelling the effect of insulin on the disposal of meal-attributable glucose in type 1 diabetes.

García-García F, Hovorka R, Wilinska ME, Elleri D, Hernando ME.

Med Biol Eng Comput. 2017 Feb;55(2):271-282. doi: 10.1007/s11517-016-1509-6. Epub 2016 May 7.

PMID:
27155940
11.

Factors Associated With Glycemic Control During Free-Living Overnight Closed-Loop Insulin Delivery in Children and Adults With Type 1 Diabetes.

Tauschmann M, Thabit H, Leelarathna L, Elleri D, Allen JM, Lubina-Solomon A, Stadler M, Walkinshaw E, Iqbal A, Choudhary P, Wilinska ME, Heller SR, Amiel SA, Evans ML, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2015 Oct 7;9(6):1346-7. doi: 10.1177/1932296815604439. No abstract available.

12.

Unsupervised overnight closed loop insulin delivery during free living: analysis of randomised cross-over home studies in adults and adolescents with type 1 diabetes.

Thabit H, Elleri D, Leelarathna L, Allen J, Lubina-Solomon A, Stadler M, Walkinshaw E, Iqbal A, Choudhary P, Wilinska M, Barnard K, Heller S, Amiel S, Evans M, Dunger D, Hovorka R.

Lancet. 2015 Feb 26;385 Suppl 1:S96. doi: 10.1016/S0140-6736(15)60411-1.

PMID:
26312919
13.

Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.

Elleri D, Biagioni M, Allen JM, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Haidar A, Calhoun P, Kollman C, Jackson NC, Umpleby AM, Acerini CL, Dunger DB, Hovorka R.

Diabetes Obes Metab. 2015 Dec;17(12):1173-9. doi: 10.1111/dom.12549. Epub 2015 Oct 9.

14.

Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.

Thabit H, Leelarathna L, Wilinska ME, Elleri D, Allen JM, Lubina-Solomon A, Walkinshaw E, Stadler M, Choudhary P, Mader JK, Dellweg S, Benesch C, Pieber TR, Arnolds S, Heller SR, Amiel SA, Dunger D, Evans ML, Hovorka R.

Diabetes Technol Ther. 2015 Nov;17(11):801-7. doi: 10.1089/dia.2015.0062. Epub 2015 Aug 4.

15.

Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3-6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial.

Ruan Y, Elleri D, Allen JM, Tauschmann M, Wilinska ME, Dunger DB, Hovorka R.

Diabetologia. 2015 Apr;58(4):687-90. doi: 10.1007/s00125-014-3483-6. Epub 2014 Dec 24.

16.

Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3-6 years: comparison between diluted and standard insulin strength.

Elleri D, Allen JM, Tauschmann M, El-Khairi R, Benitez-Aguirre P, Acerini CL, Dunger DB, Hovorka R.

BMJ Open Diabetes Res Care. 2014 Dec 11;2(1):e000040. doi: 10.1136/bmjdrc-2014-000040. eCollection 2014.

17.

Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes.

Thabit H, Elleri D, Leelarathna L, Allen JM, Lubina-Solomon A, Stadler M, Walkinshaw E, Iqbal A, Choudhary P, Wilinska ME, Barnard KD, Heller SR, Amiel SA, Evans ML, Dunger DB, Hovorka R.

Diabetes Obes Metab. 2015 May;17(5):452-8. doi: 10.1111/dom.12427. Epub 2015 Jan 9.

18.

Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents.

Barnard KD, Wysocki T, Allen JM, Elleri D, Thabit H, Leelarathna L, Gulati A, Nodale M, Dunger DB, Tinati T, Hovorka R.

BMJ Open Diabetes Res Care. 2014 Apr 16;2(1):e000025. doi: 10.1136/bmjdrc-2014-000025. eCollection 2014.

19.

Management of insulin pump therapy in children with type 1 diabetes.

Abdullah N, Pesterfield C, Elleri D, Dunger DB.

Arch Dis Child Educ Pract Ed. 2014 Dec;99(6):214-20. doi: 10.1136/archdischild-2013-304501. Epub 2014 Aug 14. Review.

PMID:
25125555
20.

Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial.

Elleri D, Maltoni G, Allen JM, Nodale M, Kumareswaran K, Leelarathna L, Thabit H, Caldwell K, Wilinska ME, Calhoun P, Kollman C, Dunger DB, Hovorka R.

Diabetes Obes Metab. 2014 Nov;16(11):1174-8. doi: 10.1111/dom.12324. Epub 2014 Jul 6.

21.

Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial.

Hovorka R, Elleri D, Thabit H, Allen JM, Leelarathna L, El-Khairi R, Kumareswaran K, Caldwell K, Calhoun P, Kollman C, Murphy HR, Acerini CL, Wilinska ME, Nodale M, Dunger DB.

Diabetes Care. 2014;37(5):1204-11. doi: 10.2337/dc13-2644.

22.

Pros and cons of GnRHa treatment for early puberty in girls.

Willemsen RH, Elleri D, Williams RM, Ong KK, Dunger DB.

Nat Rev Endocrinol. 2014 Jun;10(6):352-63. doi: 10.1038/nrendo.2014.40. Epub 2014 Apr 8. Review.

PMID:
24709660
23.

Glucose turnover after replacement of usual therapy by insulin in insulin-naive type 2 diabetes subjects.

Thabit H, Kumareswaran K, Haidar A, Leelarathna L, Caldwell K, Elleri D, Allen JM, Nodale M, Wilinska ME, Jackson NC, Umpleby AM, Evans ML, Hovorka R.

J Clin Endocrinol Metab. 2014 Jun;99(6):2225-32. doi: 10.1210/jc.2013-4519. Epub 2014 Feb 25.

PMID:
24606105
24.

Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes.

Thankamony A, Tossavainen PH, Sleigh A, Acerini C, Elleri D, Dalton RN, Jackson NC, Umpleby AM, Williams RM, Dunger DB.

J Clin Endocrinol Metab. 2014 Feb;99(2):639-47. doi: 10.1210/jc.2013-3264. Epub 2013 Dec 11.

PMID:
24423298
25.

Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management.

Luijf YM, DeVries JH, Zwinderman K, Leelarathna L, Nodale M, Caldwell K, Kumareswaran K, Elleri D, Allen JM, Wilinska ME, Evans ML, Hovorka R, Doll W, Ellmerer M, Mader JK, Renard E, Place J, Farret A, Cobelli C, Del Favero S, Dalla Man C, Avogaro A, Bruttomesso D, Filippi A, Scotton R, Magni L, Lanzola G, Di Palma F, Soru P, Toffanin C, De Nicolao G, Arnolds S, Benesch C, Heinemann L; AP@home Consortium.

Diabetes Care. 2013 Dec;36(12):3882-7. doi: 10.2337/dc12-1956. Epub 2013 Oct 29.

26.

Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetes.

Haidar A, Elleri D, Kumareswaran K, Leelarathna L, Allen JM, Caldwell K, Murphy HR, Wilinska ME, Acerini CL, Evans ML, Dunger DB, Nodale M, Hovorka R.

Diabetes Care. 2013 Oct;36(10):e173-4. doi: 10.2337/dc13-0485. No abstract available.

27.

Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study.

Kumareswaran K, Thabit H, Leelarathna L, Caldwell K, Elleri D, Allen JM, Nodale M, Wilinska ME, Evans ML, Hovorka R.

Diabetes Care. 2014;37(5):1198-203. doi: 10.2337/dc13-1030. Epub 2013 Sep 11.

PMID:
24026542
28.

Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy.

Kumareswaran K, Elleri D, Allen JM, Caldwell K, Nodale M, Wilinska ME, Amiel SA, Hovorka R, Murphy HR.

Diabetes Technol Ther. 2013 Mar;15(3):223-9. doi: 10.1089/dia.2012.0292. Epub 2013 Feb 27.

29.

Absorption patterns of meals containing complex carbohydrates in type 1 diabetes.

Elleri D, Allen JM, Harris J, Kumareswaran K, Nodale M, Leelarathna L, Acerini CL, Haidar A, Wilinska ME, Jackson N, Umpleby AM, Evans ML, Dunger DB, Hovorka R.

Diabetologia. 2013 May;56(5):1108-17. doi: 10.1007/s00125-013-2852-x. Epub 2013 Feb 23.

PMID:
23435829
30.

Physical activity energy expenditure and glucose control in pregnant women with type 1 diabetes: is 30 minutes of daily exercise enough?

Kumareswaran K, Elleri D, Allen JM, Caldwell K, Westgate K, Brage S, Raymond-Barker P, Nodale M, Wilinska ME, Amiel SA, Hovorka R, Murphy HR.

Diabetes Care. 2013 May;36(5):1095-101. doi: 10.2337/dc12-1567. Epub 2013 Feb 12.

31.

Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems.

Leelarathna L, Nodale M, Allen JM, Elleri D, Kumareswaran K, Haidar A, Caldwell K, Wilinska ME, Acerini CL, Evans ML, Murphy HR, Dunger DB, Hovorka R.

Diabetes Technol Ther. 2013 Feb;15(2):143-9. doi: 10.1089/dia.2012.0245. Epub 2012 Dec 20.

32.

Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial.

Elleri D, Allen JM, Kumareswaran K, Leelarathna L, Nodale M, Caldwell K, Cheng P, Kollman C, Haidar A, Murphy HR, Wilinska ME, Acerini CL, Dunger DB, Hovorka R.

Diabetes Care. 2013 Apr;36(4):838-44. doi: 10.2337/dc12-0816. Epub 2012 Nov 27.

33.

Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes.

Elleri D, Allen JM, Biagioni M, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Acerini CL, Dunger DB, Hovorka R.

Pediatr Diabetes. 2012 Sep;13(6):449-53. doi: 10.1111/j.1399-5448.2012.00903.x. Epub 2012 Jul 23.

PMID:
22817340
34.

Plasma C-peptide concentration in women with Type 1 diabetes during early and late pregnancy.

Murphy HR, Elleri D, Allen JM, Simmons D, Nodale M, Hovorka R.

Diabet Med. 2012 Oct;29(10):e361-4. doi: 10.1111/j.1464-5491.2012.03747.x.

PMID:
22804483
35.

Validity of triple- and dual-tracer techniques to estimate glucose appearance.

Haidar A, Elleri D, Allen JM, Harris J, Kumareswaran K, Nodale M, Acerini CL, Wilinska ME, Jackson N, Umpleby AM, Evans ML, Dunger DB, Hovorka R.

Am J Physiol Endocrinol Metab. 2012 Jun 15;302(12):E1493-501. doi: 10.1152/ajpendo.00581.2011. Epub 2012 Mar 27.

36.

Meta-analysis of overnight closed-loop randomized studies in children and adults with type 1 diabetes: the Cambridge cohort.

Kumareswaran K, Elleri D, Allen JM, Harris J, Xing D, Kollman C, Nodale M, Murphy HR, Amiel SA, Heller SR, Wilinska ME, Acerini CL, Evans ML, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1352-62.

37.

Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy.

Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, Temple RC, Umpleby AM, Dunger DB, Haidar A, Nodale M, Wilinska ME, Hovorka R.

Diabetologia. 2012 Feb;55(2):282-93. doi: 10.1007/s00125-011-2363-6. Epub 2011 Nov 12.

PMID:
22080230
38.

Closed-loop insulin delivery for treatment of type 1 diabetes.

Elleri D, Dunger DB, Hovorka R.

BMC Med. 2011 Nov 9;9:120. doi: 10.1186/1741-7015-9-120. Review.

39.

Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series.

Murphy HR, Kumareswaran K, Elleri D, Allen JM, Caldwell K, Biagioni M, Simmons D, Dunger DB, Nodale M, Wilinska ME, Amiel SA, Hovorka R.

Diabetes Care. 2011 Dec;34(12):2527-9. doi: 10.2337/dc11-1430. Epub 2011 Oct 19. Erratum in: Diabetes Care. 2012 Jan;35(1):191.

40.

Closed-loop in children with type 1 diabetes: specific challenges.

Elleri D, Allen JM, Dunger DB, Hovorkea R.

Diabetes Res Clin Pract. 2011 Aug;93 Suppl 1:S131-5. doi: 10.1016/S0168-8227(11)70029-8. Review.

PMID:
21864745
41.

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies.

Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML.

BMJ. 2011 Apr 13;342:d1855. doi: 10.1136/bmj.d1855.

42.

Automated overnight closed-loop glucose control in young children with type 1 diabetes.

Elleri D, Allen JM, Nodale M, Wilinska ME, Mangat JS, Larsen AM, Acerini CL, Dunger DB, Hovorka R.

Diabetes Technol Ther. 2011 Apr;13(4):419-24. doi: 10.1089/dia.2010.0176. Epub 2011 Feb 28.

PMID:
21355719
43.

Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes.

Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, Temple R, Dunger DB, Haidar A, Nodale M, Wilinska ME, Hovorka R.

Diabetes Care. 2011 Feb;34(2):406-11. doi: 10.2337/dc10-1796. Epub 2011 Jan 7.

44.

Suspended insulin infusion during overnight closed-loop glucose control in children and adolescents with Type 1 diabetes.

Elleri D, Allen JM, Nodale M, Wilinska ME, Acerini CL, Dunger DB, Hovorka R.

Diabet Med. 2010 Apr;27(4):480-4. doi: 10.1111/j.1464-5491.2010.02964.x.

PMID:
20536523
45.

Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.

Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1109-20.

46.

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.

Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB.

Lancet. 2010 Feb 27;375(9716):743-51. doi: 10.1016/S0140-6736(09)61998-X. Epub 2010 Feb 4.

47.

Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes.

Elleri D, Acerini CL, Allen JM, Hayes J, Pesterfield C, Wilinska ME, Dunger DB, Hovorka R.

Diabetes Technol Ther. 2010 Jan;12(1):35-9. doi: 10.1089/dia.2009.0084.

PMID:
20082583
48.

Effect of delay on measurement of blood glucose levels in young subjects with type 1 diabetes.

Elleri D, Acerini CL, Allen JM, Larsen AM, Wilinska ME, Dunger DB, Hovorka R.

Diabetes Res Clin Pract. 2009 Nov;86(2):e31-3. doi: 10.1016/j.diabres.2009.06.025. Epub 2009 Jul 29.

PMID:
19643507
49.

Gastrointestinal lesions in parvovirus B19 infection.

Tassinari D, Gallinella G, Salfi NC, Elleri D, Forti S, Bonvicini F, Bernardi F.

BMJ Case Rep. 2009;2009. pii: bcr10.2008.1058. doi: 10.1136/bcr.10.2008.1058. Epub 2009 Mar 17.

50.

Quality of life, psychological adjustment and metabolic control in youths with type 1 diabetes: a study with self- and parent-report questionnaires.

Nardi L, Zucchini S, D'Alberton F, Salardi S, Maltoni G, Bisacchi N, Elleri D, Cicognani A.

Pediatr Diabetes. 2008 Oct;9(5):496-503. doi: 10.1111/j.1399-5448.2008.00414.x. Epub 2008 May 28.

PMID:
18507786

Supplemental Content

Loading ...
Support Center